Business Context and Reporting Period
Company: Keros Therapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 6, 2025
Reporting Period: Single event date (June 6, 2025)
This filing serves as a Regulation FD disclosure regarding an upcoming corporate event. It does not contain periodic financial results.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report focused on a specific disclosure event rather than a financial statement.
Material Changes
No material financial changes or operational updates are reported in this filing. The document solely announces a scheduled presentation by company leadership.
Guidance, Outlook, and Management Commentary
- Upcoming Event: Jasbir Seehra, Chair and Chief Executive Officer, is scheduled to participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference.
- Event Date: Monday, June 9, 2025.
- Event Time: 9:20 a.m. Eastern time.
- Legal Disclaimer: The information in this report and the accompanying press release (Exhibit 99.1) is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act. It is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the date and time of the Goldman Sachs 46th Annual Global Healthcare Conference presentation (June 9, 2025, 9:20 a.m. ET).
- Review the full text of the press release attached as Exhibit 99.1 for any additional details on the presentation topic.
- Confirm that no financial data or forward-looking guidance was included in this specific 8-K filing.